News

After the results of a study found high dairy intake was associated with increased prostate cancer risk, the authors urge men already at a higher-than-average risk of prostate cancer to be cautious about dairy intake.

Research shows that a synthetic IL-9 receptor allows cancer-fighting T cells to do their work without the need for chemo or radiation.

A review of medical records has revealed racial disparities in patients receiving immunotherapy to treat stage 3 or 4 liver cancer.

Findings confirm a clinical complete response in all 14 patients who received dostarlimab as a first-line treatment for mismatch repair-deficient locally advanced rectal cancer.

Scientists have discovered that in esophageal and stomach cancer, chronic inflammation causes oxidative stress, leading to the transformation of healthy cells into cancer cells by damaging DNA.

A drug combination targeting multiple mutant versions of KRAS, which researchers termed cancer’s "death star" protein, has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer.

A newly identified gene variation could inform clinicians which patients are more susceptible to developing stomach cancer.

The primary causes of liver cancer are changing worldwide – with non-alcoholic steatohepatitis the fastest-growing cause of liver cancer deaths globally.

According to a study, a newly synthesized compound kills a range of hard-to-treat cancer types by targeting a previously unexploited vulnerability.

A randomized clinical trial found that a combination of immunotherapy and chemotherapy treatment boosted the one-year survival rate of pancreatic cancer by over 60%.